The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice.

@article{Crowe2017TheML,
  title={The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice.},
  author={Molly S Crowe and Catheryn D Wilson and Emma Leishman and Paul L. Prather and Heather B. Bradshaw and Matthew L Banks and Steven G Kinsey},
  journal={British journal of pharmacology},
  year={2017},
  volume={174 23},
  pages={
          4523-4539
        }
}
BACKGROUND AND PURPOSE Gabapentin is commonly prescribed for nerve pain but may also cause dizziness, sedation and gait disturbances. Similarly, inhibition of the endogenous cannabinoid enzyme monoacylglycerol lipase (MAGL) has antinociceptive and anti-inflammatory properties but also induces sedation in mice at high doses. To limit these side effects, the present study investigated the analgesic effects of coadministering a MAGL inhibitor with gabapentin. EXPERIMENTAL APPROACH Mice subjected… CONTINUE READING